Sign in

CIK 0001831283 · <br>Emerging growth company

Ticker
LIANY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
operating
Phone
(609) 486-2308
Business address
103 CARNEGIE CENTER DRIVE, SUITE 309, PRINCETON, NJ, 08540
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-11-03 PERCEPTIVE ADVISORS LLC Director Conversion +2,477,005 2,477,005
2021-11-03 PERCEPTIVE ADVISORS LLC Director Conversion · Series A Preferred Shares −635,369 0
2021-11-03 PERCEPTIVE ADVISORS LLC Director Conversion · Series Seed Preferred Shares −2,500,000 0
2021-11-03 PERCEPTIVE ADVISORS LLC Director Conversion · Series Seed Preferred Shares −2,500,000 0
2021-11-03 PERCEPTIVE ADVISORS LLC Director Conversion · Series Seed Preferred Shares −500,000 0
2021-11-03 PERCEPTIVE ADVISORS LLC Director Conversion · Series A Preferred Shares −423,579 0
2021-11-02 PERCEPTIVE ADVISORS LLC Director Purchase +100,000 $13.50 $1.4M 7,253,885
2021-11-01 PERCEPTIVE ADVISORS LLC Director Purchase +120,000 $15.50 $1.9M 7,153,885
2021-10-31 QIAN JIANG China General Manager Grant or award · Stock Option (Right to Buy) +409,343 409,343
2021-10-31 Silbermann Susan Michele Director Grant or award · Stock Option (Right to Buy) +72,600 72,600
2021-10-31 Jahn Brianne Chief Business Officer Grant or award · Stock Option (Right to Buy) +330,942 915,722
2021-10-31 Wu Jesse Director Grant or award · Stock Option (Right to Buy) −72,600 72,600
2021-10-31 Larson Yi Chief Financial Officer Grant or award · Stock Option (Right to Buy) +229,538 1,196,845
2021-10-31 Yu Debra See Remarks Grant or award · Stock Option (Right to Buy) +747,227 2,747,174

Page 4 of 4 · 74 trades